Chemokine Oligomers and the Impact of Fondaparinux Binding

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Heparin, a widely used clinical anticoagulant, is generally well-tolerated; however, approximately 1% of patients develop heparin-induced thrombocytopenia (HIT), a serious side effect. While efforts to understand the role of chemokines in HIT development are ongoing, certain aspects remain less studied, such as the stabilization of chemokine oligomers by heparin. Here, we conducted a combined ion mobility-native mass spectrometry study to investigate the stability of chemokine oligomers and their complexes with fondaparinux, a synthetic heparin analog. Collision-induced dissociation and unfolding experiments provided clarity on the specificity and relevance of chemokine oligomers and their fondaparinux complexes with varying stoichiometries, as well as the stabilizing effects of fondaparinux binding.
OriginalsprogEngelsk
TidsskriftJournal of the American Society for Mass Spectrometry
ISSN1044-0305
DOI
StatusE-pub ahead of print - 2024

Bibliografisk note

Funding Information:
Financial support for this research was provided by the European Union\u2019s Horizon 2020 Research and Innovation Programme grant number 899687-HS-SEQ. D.P.D. was supported by a Sir Henry Dale fellowship jointly funded by the Wellcome Trust and Royal Society (Grant Number 218570/Z/19/Z) and a Wellcome Trust centre grant (Grant Number 203128/A/16/Z). R.L.M. was supported by The Novo Nordisk Foundation grant NNF22OC0073736. G.P.S. and K.P. acknowledge the support from the SupraFAB research building realized with funds from the federal government and the city of Berlin.

Publisher Copyright:
© 2024 The Authors. Published by American Chemical Society.

ID: 395088401